Analytical Data
-
Gene name
CCL9
- Application
-
Alternative Names
CCL9；Toll-like receptor 6
-
Species
Mouse
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P51670
-
Expression Region
22-122aa
-
AA Sequence
QITHATETKE VQSSLKAQQG LEIEMFHMGF QDSSDCCLSY NSRIQCSRFI GYFPTSGGCT RPGIIFISKR GFQVCANPSD RRVQRCIERL EQNSQPRTYK Q
-
Molecular Weight
11.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CCL9, also known as Chemokine (C-C motif) ligand 9, is a chemokine that plays a crucial role in immune responses and inflammatory processes. It is primarily involved in the recruitment of immune cells, particularly monocytes and T cells, to sites of inflammation. Research on CCL9 has gained significant attention due to its potential implications in various diseases, including autoimmune disorders, infections, and cancer. The ability of CCL9 to modulate immune responses makes it a promising candidate for therapeutic interventions. Recombinant CCL9 proteins have been developed to study their biological functions and mechanisms of action in vitro and in vivo. These studies aim to elucidate the role of CCL9 in mediating immune cell migration, activation, and differentiation. Additionally, understanding the signaling pathways activated by CCL9 can provide insights into its function within the immune system. Given its involvement in pathological conditions, targeting CCL9 or its receptors might offer new strategies for treating diseases characterized by dysregulated immune responses. As such, the research on CCL9 recombinant proteins is essential for developing innovative therapies and understanding the complexities of immune system regulation.
